Fuling Technology
001356
KLT
831689
Hand Enterprise Solutions
300170
GRANDTECH
835184
Doushen(Beijing) Education & Technology Inc.
300010
CN Stock MarketDetailed Quotes
002399 Shenzhen Hepalink Pharmaceutical Group
- 10.15
- 0.000.00%
Market Closed Jan 23 15:00 CST
14.89BMarket Cap-101.50P/E (TTM)
10.33High10.14Low33.58KlotVolume10.17Open10.15Pre Close34.42MTurnover0.27%Turnover RatioLossP/E (Static)1.47BShares12.5452wk High1.23P/B12.66BFloat Cap6.8952wk Low11.17Limit Up1.25BShs Float56.04Historical High9.14Limit Down1.87%Amplitude6.89Historical Low--Dividend TTM10.25Avg Price14.15KlotAsk--Div YieldTTM100Lot Size18.56KlotBid
Shenzhen Hepalink Pharmaceutical Group Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 0.14%4.07B | 4.59%2.84B | 5.55%1.37B | -23.94%5.45B | -24.69%4.06B | -27.82%2.71B | -31.90%1.3B | 12.48%7.16B | 16.49%5.4B | 20.72%3.76B |
| Operating revenue | 0.14%4.07B | 4.59%2.84B | 5.55%1.37B | -23.94%5.45B | -24.69%4.06B | -27.82%2.71B | -31.90%1.3B | 12.48%7.16B | 16.49%5.4B | 20.72%3.76B |
| Other operating revenue | ---- | 51.81%41.87M | ---- | -0.22%61.79M | ---- | 12.93%27.58M | ---- | 30.84%61.92M | ---- | 21.07%24.42M |
| Total operating cost | -3.71%3.53B | 1.44%2.4B | -4.43%1.18B | -18.90%4.94B | -17.89%3.67B | -22.91%2.36B | -25.21%1.24B | 5.17%6.09B | 8.97%4.47B | 11.06%3.07B |
| Operating cost | -0.10%2.72B | 5.25%1.85B | 6.21%899.55M | -24.45%3.65B | -25.55%2.72B | -30.67%1.76B | -36.37%846.99M | 11.38%4.83B | 15.11%3.65B | 18.90%2.53B |
| Operating tax surcharges | -6.71%11.94M | -7.39%8.46M | 10.71%4.98M | 5.18%23.9M | 39.08%12.8M | 52.91%9.13M | 66.14%4.5M | 8.44%22.73M | -2.35%9.21M | -8.76%5.97M |
| Operating expense | -30.26%280.98M | -38.19%191.91M | -45.34%92.31M | -0.21%517.42M | 9.16%402.92M | 27.48%310.49M | 40.39%168.88M | 20.44%518.5M | 25.52%369.12M | 24.87%243.56M |
| Administration expense | 0.90%309M | -12.78%189.28M | -19.87%89.6M | 0.30%458.57M | -5.06%306.24M | 2.50%217.02M | 15.44%111.82M | 8.81%457.19M | 14.19%322.56M | 9.62%211.73M |
| Financial expense | 11.88%82.96M | 430.87%79.12M | -22.20%62.73M | 576.19%113.31M | 238.56%74.15M | -254.84%-23.91M | -5.30%80.63M | -95.45%16.76M | -123.17%-53.52M | -103.79%-6.74M |
| -Interest expense (Financial expense) | -35.80%110.55M | -31.52%79.56M | -26.62%45.14M | -5.11%223.22M | 2.34%172.19M | 4.36%116.18M | 22.68%61.51M | 16.67%235.24M | 10.93%168.24M | 7.46%111.33M |
| -Interest Income (Financial expense) | 2.18%-33.29M | 24.16%-18.6M | 15.49%-9.51M | 27.00%-39.52M | 16.81%-34.03M | 15.45%-24.52M | 14.88%-11.25M | 1.31%-54.14M | 3.25%-40.91M | -10.43%-29M |
| Research and development | -14.61%129.98M | -15.02%81.04M | 33.11%35.29M | -27.65%182.43M | -8.63%152.22M | 20.55%95.36M | 26.96%26.51M | 14.04%252.14M | 52.92%166.59M | 35.76%79.1M |
| Credit Impairment Loss | 455.16%11M | 371.07%11.45M | -0.93%5.03M | 63.08%-22.55M | 81.90%-3.1M | 54.36%-4.22M | 152.54%5.08M | 40.11%-61.07M | -45.07%-17.11M | 13.05%-9.25M |
| Asset Impairment Loss | 408.61%28.23M | 157.56%13.93M | 618.78%33.75M | -2,583.92%-977.85M | 224.04%5.55M | 242.62%5.41M | 448.41%4.7M | 85.88%-36.43M | -53.08%-4.48M | -29.57%-3.79M |
| Other net revenue | 270.54%367.34M | 287.48%344.89M | -32.65%8.06M | -472.66%-1.37B | -154.14%-215.4M | -202.34%-183.97M | -60.40%11.97M | 30.87%-238.46M | -389.50%-84.76M | -189.57%-60.85M |
| Fair value change income | -364.77%-98.35M | -429.70%-95.35M | 161.07%27.62M | 123.98%17.33M | 351.88%37.14M | 301.53%28.92M | -82.62%10.58M | -213.11%-72.26M | -114.20%-14.75M | -1,174.83%-14.35M |
| Invest income | 251.52%416.44M | 281.69%411.16M | -351.41%-61.89M | -285.03%-402.93M | -235.49%-274.83M | -372.51%-226.3M | 55.19%-13.71M | -54.78%-104.65M | -405.84%-81.92M | -178.43%-47.89M |
| -Including: Investment income associates | 68.20%-90.07M | 66.52%-77.76M | -125.32%-46.19M | -354.95%-447.95M | -239.67%-283.24M | -322.41%-232.29M | 43.43%-20.5M | 18.17%-98.46M | -227.47%-83.39M | -679.74%-54.99M |
| Asset deal income | 212.88%620.16K | -227.77%-583.34K | -71.48%28.61K | 42.05%-1.6M | -170.69%-549.39K | 868.69%456.57K | 73.94%100.32K | 45.92%-2.76M | -59.70%777.18K | -97.45%47.13K |
| Other revenue | -53.92%9.39M | -63.60%4.28M | -32.70%3.51M | -43.12%22.02M | -37.70%20.38M | -18.23%11.77M | -52.03%5.22M | 62.19%38.71M | 47.61%32.72M | -16.58%14.39M |
| Operating profit | 405.25%903.48M | 377.79%783.34M | 167.28%196.85M | -203.90%-860.91M | -78.76%178.82M | -73.97%163.95M | -74.02%73.65M | 264.27%828.62M | 50.33%841.91M | 50.28%629.95M |
| Add:Non operating Income | -85.37%944.57K | -96.56%213.26K | -99.48%29.35K | 286.14%11.1M | 2,656.70%6.46M | 6,476.76%6.21M | 32,433.15%5.63M | 1,046.31%2.88M | 199.57%234.28K | 320.37%94.4K |
| Less:Non operating expense | 319.69%17.22M | 554.42%15.91M | 808.54%15.67M | 4,664.87%78.53M | 289.55%4.1M | 142.75%2.43M | 100.95%1.72M | -69.83%1.65M | -83.64%1.05M | -77.14%1M |
| Total profit | 389.69%887.2M | 357.67%767.65M | 133.64%181.21M | -211.87%-928.33M | -78.46%181.17M | -73.34%167.73M | -72.56%77.56M | 273.36%829.85M | 51.91%841.1M | 51.64%629.04M |
| Less:Income tax cost | 175.25%108.14M | 131.06%104.81M | 129.20%26.61M | -209.89%-126.17M | -79.43%39.29M | -61.76%45.36M | -75.51%11.61M | 1,132.47%114.82M | 97.75%191.03M | 51.47%118.64M |
| Net profit | 449.08%779.06M | 441.68%662.84M | 134.42%154.6M | -212.18%-802.16M | -78.17%141.89M | -76.03%122.37M | -71.97%65.95M | 206.38%715.04M | 42.23%650.06M | 51.68%510.4M |
| Net profit from continuing operation | 449.08%779.06M | 441.68%662.84M | 134.42%154.6M | -212.18%-802.16M | -78.17%141.89M | -76.03%122.37M | -71.97%65.95M | 206.38%715.04M | 42.23%650.06M | 51.68%510.4M |
| Less:Minority Profit | 17.91%-1.05M | 13.78%-847.76K | 25.19%-442.43K | -52.55%-18.9M | 41.45%-1.28M | -33.55%-983.2K | -299.90%-591.38K | -67.34%-12.39M | 50.61%-2.19M | 55.72%-736.21K |
| Net profit of parent company owners | 444.89%780.11M | 438.05%663.68M | 133.00%155.04M | -207.68%-783.26M | -78.05%143.17M | -75.87%123.35M | -71.68%66.54M | 202.10%727.43M | 41.33%652.26M | 51.15%511.14M |
| Earning per share | ||||||||||
| Basic earning per share | 444.77%0.5317 | 437.81%0.4523 | 133.33%0.1057 | -207.73%-0.5338 | -78.04%0.0976 | -75.86%0.0841 | -71.71%0.0453 | 201.95%0.4955 | 41.34%0.4445 | 51.15%0.3484 |
| Diluted earning per share | 444.77%0.5317 | 437.81%0.4523 | 133.33%0.1057 | -207.73%-0.5338 | -78.04%0.0976 | -75.86%0.0841 | -71.71%0.0453 | 201.95%0.4955 | 41.34%0.4445 | 51.15%0.3484 |
| Other composite income | -164.91%-65.62M | -57.81%45.5M | -9.06%-4.46M | -89.35%32.98M | -73.20%101.09M | -43.44%107.83M | 9.72%-4.09M | 454.91%309.63M | 12,597.95%377.19M | 4,524.83%190.66M |
| Other composite income of parent company owners | -164.94%-65.59M | -57.79%45.48M | -10.21%-4.47M | -89.34%32.93M | -73.12%101.01M | -43.30%107.73M | 19.97%-4.05M | 455.43%308.88M | 12,100.11%375.82M | 4,684.21%190.02M |
| Other composite income of minority owners | -134.68%-30.22K | -82.10%17.69K | 112.96%4.94K | -93.55%48.46K | -93.65%87.16K | -84.49%98.83K | -107.16%-38.1K | 321.11%750.88K | 1,347.37%1.37M | 489.17%637.07K |
| Total composite income | 193.62%713.44M | 207.70%708.33M | 142.71%150.14M | -175.07%-769.18M | -76.35%242.98M | -67.16%230.2M | -73.19%61.86M | 601.15%1.02B | 123.30%1.03B | 111.04%701.06M |
| Total composite income of parent company owners | 192.63%714.52M | 206.89%709.16M | 140.97%150.57M | -172.40%-750.32M | -76.25%244.18M | -67.04%231.08M | -72.82%62.49M | 573.43%1.04B | 121.29%1.03B | 109.92%701.16M |
| Total composite income of minority owners | 9.41%-1.08M | 6.14%-830.08K | 30.50%-437.49K | -61.97%-18.85M | -45.59%-1.2M | -792.01%-884.38K | -175.99%-629.48K | -50.31%-11.64M | 81.93%-822.53K | 94.57%-99.14K |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion with explanatory notes | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Ernst & Young Huaming Certified Public Accountants (Special General Partnership) | -- | -- | -- | Ernst & Young Huaming Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
